Sharkey, R M <br/><br/>
Phase I clinical evaluation of a new murine monoclonal antibody (Mu-9) against colon-specific antigen-p for targeting gastrointestinal carcinomas.  [electronic resource] 

 -  Cancer  Feb 1994 
 - 864-77 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase I; Controlled Clinical Trial; Journal Article; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0008-543X 
<br/><br/><label>Standard No.: </label>10.1002/1097-0142(19940201)73:3+<864::aid-cncr2820731318>3.0.co;2-9  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Animals<br/>Antibodies, Monoclonal--metabolism<br/>Antibody Formation<br/>Antigens, Neoplasm--immunology<br/>Biomarkers, Tumor<br/>Female<br/>Gastrointestinal Neoplasms--therapy<br/>Half-Life<br/>Humans<br/>Immunoglobulin Fab Fragments--immunology<br/>Immunoglobulin G--immunology<br/>Iodine Radioisotopes--pharmacokinetics<br/>Male<br/>Mice--immunology<br/>Middle Aged<br/>Radioimmunotherapy<br/>Radiotherapy Dosage<br/>Tissue Distribution